SIGN IN to access Harper’s Magazine
1. Sign in to Customer Care using your account number or postal address.
2. Select Email/Password Information.
3. Enter your new information and click on Save My Changes.
Subscribers can find additional help here. Not a subscriber? Subscribe today!
When he was seeking reelection in 2006, Joe Lieberman campaigned as a supporter of healthcare reform and expressed his support for “universal healthcare.” When the rubber hit the road, however, Lieberman emerged as a frontline warrior for the healthcare industry in its efforts to block reform. Yesterday, he not only noted his opposition to the very modest public option contained in the legislation that Majority Leader Harry Reid put forward, he also stated that he would cross the aisles to support a Republican filibuster. Should we be surprised? No. Lieberman has long been one of the industry’s favorite players on the hill, accepting more than $1 million in campaign contributions from the insurance industry and more than $600,000 from pharmaceuticals and related healthcare-products companies. But his ties run deeper than that. His wife Hadassah previously worked for two lobbying firms, Hill & Knowlton and APCO, handling matters for their healthcare and pharmaceuticals clients. Throughout the 2006 campaign, Lieberman pointedly refused to discuss the scope of his wife’s engagement for the healthcare industry or even the specific clients for whom she was working. But there seems to have been plenty of opportunity for synergy with Lieberman’s work in Congress. Joe Conason noted:
Among Hill & Knowlton’s clients when Mrs. Lieberman signed on with the firm last year was GlaxoSmithKline, the huge British-based drug company that makes vaccines along with many other drugs. As I noted in July, Sen. Lieberman introduced a bill in April 2005 (the month after his wife joined Hill & Knowlton) that would award billions of dollars in new “incentives” to companies like GlaxoSmithKline to persuade them to make more new vaccines. Under the legislation, known as Bioshield II, the cost to consumers and governments would be astronomical, but for Lieberman and his Republican cosponsors, Sen. Orrin Hatch, R-Utah, and Sen. Sam Brownback, R-Kan., the results would be worth every penny. Using the war on terror as their ideological backdrop, the pharma-friendly senators sought to win patent extensions on products that have nothing to do with preparations against terrorist attack or natural disaster.
As the New Haven Register, Lieberman’s hometown newspaper, noted in an editorial headlined “Lieberman Crafts Drug Company Perk,” that bill is even more generous to the pharmaceutical industry than a similar proposal by the Senate Republican leadership. “The government can offer incentives and guarantees for needed public health measures,” it said. “But it should not write a blank check, as these bills do, to the pharmaceutical industry that has such a large cost to the public with what may be an uncertain or dubious return.” What the editorial didn’t mention was that the Lieberman bill had also been written by Chuck Ludlam, a former pharmaceutical industry lobbyist who then worked on the Connecticut senator’s staff. From his office to his bedroom, Lieberman was totally surrounded by current and former employees of Big Pharma. Ludlam has since retired, and Mrs. Lieberman has quit her job too — but Lieberman still looks like a politician wholly owned by one of the nation’s most troublesome special interests. And while his campaign may not believe that the moralizing senator should be held accountable for those dubious relationships, the press and the public may think otherwise.
More from Scott Horton:
Conversation — August 5, 2016, 12:08 pm
Sidney Blumenthal on the origins of the Republican Party, the fallout from Clinton’s emails, and his new biography of Abraham Lincoln
Conversation — March 30, 2016, 3:44 pm
Joseph Hickman discusses his new book, The Burn Pits, which tells the story of thousands of U.S. soldiers who, after returning from Iraq and Afghanistan, have developed rare cancers and respiratory diseases.
Flor Arely Sánchez had been in bed with a fever and pains throughout her body for three days when a July thunderstorm broke over the mountainside. She got nervous when bolts of light flashed in the sky. Lightning strikes the San Julián region of western El Salvador several times a year, and her neighbors fear storms more than they fear the march of diseases — first dengue, then chikungunya, now Zika. Flor worried about a lot of things, since she was pregnant.
Late in the afternoon, when the pains had somewhat eased, Flor thought she might go to a dammed-up bit of the river near her house to bathe. She is thirty-five and has lived in the same place all her life, where wrinkled hills are planted with corn, beans, and fruit trees. She took a towel and soap and walked out into the rain. Halfway to the river, the pains returned and overcame her. The next thing Flor remembers, she was in a room she didn’t recognize, unable to move. As she soon discovered, she was in a hospital, her ankle cuffed to the bed, and she was being investigated for abortion.
Average number of new microwave food products introduced every day In 1987:
Cocaine addicts prefer $500 in cash now to $1,000 worth of cocaine later.
Scientists in the Galápagos Islands credited an endangered giant tortoise named Diego with saving his species by fathering more than 800 offspring.
Subscribe to the Weekly Review newsletter. Don’t worry, we won’t sell your email address!
“Matt was happy enough to sustain himself on the detritus of a world he saw as careening toward self-destruction, and equally happy to scam a government he despised. 'I’m glad everyone’s so wasteful,' he told me. 'It supports my lifestyle.'”